A Peptide-Based Neoantigen Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment
2020
e14563Background: Tumor-specific neoantigens are considered as personalized and potential ultimate targets for cancer immunotherapy. Recently, neoantigen cancer vaccines have been designed to train...
-
Correction
-
Source
-
Cite
-
Save
0
References
1
Citations
NaN
KQI